Brequinar Combined With Dipyridamole in Patients With Mild to Moderate COVID-19
Clinical trial NCT05166876 · TERMINATED
Trial details
- NCT number
- NCT05166876
- Sponsor
- Clear Creek Bio, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-01
- Primary completion
- 2022-06-04
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.